Categories: Therapy Response Assessment

WUSTL: Discrepant Assessments of Progressive Disease in Clinical Trials between Routine Clinical Reads and Formal RECIST 1.1 Interpretations

In this retrospective study utilizing the mint Lesion™ software[1], researchers found that routine clinical interpretations frequently resulted in the…

Tumor Growth Rate Modeling: A Novel Approach to Evaluating the Efficacy of Cancer Therapies

The 2020 review of Clinical Trial Evidence Supporting US Food and Drug Administrative Approval of Novel Cancer Therapies Between 2000 and 2016…

Raising our awareness in pediatric cancer

The terms rare, uncommon, infrequent are commonly used to describe the occurrence of cancer in children –  from a prevalence perspective, “only”…

Enhancing flexibility and communication while saving costs and time in clinical trials

University Hospital Jena: Next-level Workflow Optimization in Clinical Trials

How to set up a well-running clinical trial center that can handle up to 40 trials at once has been successfully demonstrated by Laura Graziani, study…

University of Miami & Nova Souteastern University: Study shows feasibility of radiomics and T2 mapping as novel imaging biomarkers of activity in superficial fibromatosis

A retrospective study [1] conducted by researchers at University of Miami Miller School of Medicine and Nova Southeastern University investigated…

Quantitative Tumorbegleitung und ihre Einbettung in holistische Befundstrukturen (Only in German)

Workflow optimization, increased efficiency and reduced errors in clinical trials